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Adipogenesis is a key differentiation process relevant to obe-
sity and associated diseases such as type 2 diabetes. This process
involves temporally regulated genes controlled by a set of tran-
scription factors, CCAAT/enhancer-binding proteins (C/EBP)
, C/EBP, and C/EBP and peroxisome proliferator-activated
receptor  (PPAR). Currently, PPAR is universally accepted
as themaster regulator that is necessary and sufficient to induce
adipogenesis as no known factor can induce adipogenesis with-
out PPAR. We present evidence that a novel zinc finger pro-
tein, MCP-1-induced protein (MCPIP), can induce adipogene-
sis without PPAR. Classical adipogenesis-inducing medium
inducesMCP-1 production and expression ofMCPIP in 3T3-L1
cells before the induction of the C/EBP family of transcription
factors and PPAR. Knockdown of MCPIP prevents their
expression and adipogenesis as measured by expression of adi-
pocyte markers and lipid droplet accumulation. Treatment of
3T3-L1 cells with MCP-1 or forced expression of MCPIP
induces expression of C/EBP, C/EBP, C/EBP, and PPAR
and adipogenesis without any other inducer. Forced expression
of MCPIP induces expression of the C/EBP family of transcrip-
tion factors and adipogenesis in PPAR/ mouse embryonic
fibroblasts. Thus, MCPIP is a newly identified protein that can
induce adipogenesis without PPAR.
The incidence of obesity and associated diseases is increasing
dramatically throughout the world. The global incidence of
type 2 diabetes is projected to double to 350million cases by the
year 2030 (1). Because adipose tissue serves as a crucial integra-
tor of glucose homeostasis, understanding of adipocyte biology
is crucial for understanding the pathophysiological basis of
obesity and related metabolic diseases (2, 3). Adipogenesis and
angiogenesis, which supply blood to the growing adipose tissue,
occur in the growing adipose tissue when the caloric intake
significantly exceeds caloric expenditure. Adipogenesis in-
volves a temporally regulated set of gene expression controlled
by a set of transcription factors (3, 4). C/EBP2 and C/EBP are
induced early, followed by C/EBP and PPAR. It is widely
accepted that PPAR is themaster regulator of adipogenesis (2,
4). This conclusion is based mainly on the finding that forced
expression of PPAR in C/EBP/ fibroblasts induces adipo-
genesis (5), whereas forced expression of C/EBP in PPAR/
fibroblasts does not induce adipogenesis (6). Thus, the current
concept is that PPAR is both necessary and sufficient for adi-
pogenesis. No other factor is known that can induce adipogen-
esis in the absence of PPAR (7). Here we report that a newly
discovered zinc finger protein, MCP-1-induced protein
(MCPIP) (8), induces adipogenesis in the absence of PPAR. In
an engineered tissue model, MCP-1 treatment was reported to
enhance adipose tissue volume (9). In 3T3-L1 cells undergoing
adipogenesis in the commonly used adipogenesis-inducing
medium, containing dexamethasone, 3-isobutyl-1-methylxan-
thine, and insulin (DMI), MCP-1 is produced, and MCPIP is
induced before the induction of the C/EBP family of transcrip-
tion factors and PPAR. Knockdown of MCPIP with siRNA
inhibits induction of these genes and adipogenesis. Treatment
of 3T3-L1 cells with MCP-1 or forced expression of MCPIP
induces adipogenesis without the adipogenesis-inducing DMI
medium. Forced expression of MCPIP induces adipogenesis in
PPAR/mouse embryonic fibroblasts (MEF). Thus, MCPIP
is a newly identified inducer of adipogenesis.
EXPERIMENTAL PROCEDURES
Cell Culture—The 3T3-L1 fibroblast cell line was obtained
from the American Type Culture Collection (ATCC).
PPAR/ MEF cell line was obtained from Dr. Bruce
Spiegelman, Harvard University. Cells weremaintained in Dul-
becco’s modified Eagle’s medium with 1% penicillin/strepto-
mycin and 10% fetal bovine serum until experimentation. Cells
growing on plates at 60% confluency were treated with or with-
out 10 ng/ml MCP-1 for 7 days. Adipocyte differentiation was
induced by replacingDulbecco’smodified Eagle’smediumwith
media containing DMI (Zen-Bio, Inc.). Construction of the
MCPIP-GFP expression plasmid has been described previously
(8). Cells were transfected with 100 nmol/liter of a chemically
synthesized siRNA targeted for MCPIP (Ambion) or with 100
nmol/liter nonspecific siRNA (Ambion) 12 h prior to treatment
with DMI. All cells types were transfected using FuGENE HD
(Roche Applied Science).
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FIGURE 1. 3T3-L1 fibroblasts produced MCP-1 when treated with DMI, and MCP-1 treatment of 3T3-L1 fibroblasts induced MCPIP expression and
adipogenesis. A, 3T3-L1 cells were treatedwith orwithout DMI. RNAwas isolated, andMCP-1 transcript levels weremeasured using real time RT-PCR (* p
0.02).Ct values of treated/untreated are displayed. B, 3T3-L1 cells grown to 60% confluency were treated with or without 10 ng/ml MCP-1 protein for 7
days. RNA and cell lysate were collected 1, 3, 5, and 7 days after treatment. Transcript levels of the adipogenesis markers C/EBP, C/EBP, C/EBP, and PPAR
weremeasured using real time RT-PCR (* p 0.02; # p 0.03). C, protein levels of C/EBP, C/EBP, C/EBP, and PPARweremeasured using immunoblot
analysis. Resultswerequantified againstGAPDH.D, RNAand cell lysatewere collected 7days afterMCP-1 treatment. Real timeRT-PCRwasused tomeasure the
adipogenesis markers adiponectin (Adipo), LPL, and AP2 (normalized to -actin,Ct values of treated/untreated are displayed; * p 0.02). E, protein
levels of adiponectin, LPL, andAP2weremeasuredusing immunoblot analysis. Resultswere quantified against GAPDH (*p 0.02). F, cellswere stainedwith
Oil Red-O 8 days after MCP-1 treatment. G, MCPIP transcript levels were measured using real time RT-PCR (normalized to -actin,Ct values of treated/
untreated are displayed). Protein levels of MCPIP were measured using immunoblot analysis. Results were quantified against GAPDH (* p 0.02; # p
0.03). All experiments were repeated three times.
Adipogenesis Induction byMCPIP without PPAR
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Oil Red-O—3T3-L1 or PPAR/MEF cells were fixed with
10% formalin for 30 min at room temperature 8 days after
experimental treatment. Cells were then washed with 60% iso-
propyl alcohol followed by treatment with Oil Red-O (2.1
mg/ml) for 20 min at room temperature. Samples were then
washed four times with H2O. Images of sample plates stained
with Oil Red-O were taken and analyzed using morphometric
software analysis. Oil Red-O was evaluated by measuring total
objects stained, area of plate stained, and total intensity of
stained area. All three methods yielded similar results. After
examining the plates microscopically, they were treated with
100% isopropyl alcohol to extract Oil Red-O. The solution was
then measured for absorbance at 520 nm.
RT-PCR—Total RNA was isolated from treated fibroblasts
using TRIzol (Invitrogen). First-strand cDNA was synthesized
using 1 g of total RNA (DNase-treated) using the RT cDNA
synthesis kit (High Capacity, Applied Biosystems). -Actin
served as internal control. The primer set forward 5-ctccaatgt-
tctcaaacttac-3 and reverse 5-gtattcctatggcttccagtgc-3 was
used to detect a 400-bp product in the PPAR/MEF cell line
to confirm the deletion of exon 2 in PPAR (9).
Immunoblot Analysis—3T3-L1 and PPAR/ MEFs were
treated with cell lysis buffer (20% glycerol, 0.1% Triton X-100,
8% 0.5 MEDTA, and 1% 1Mdithiothreitol), and protein samples
were collected and subjected to immunoblot using polyclonal
antibodies specific for MCPIP (1:2000), C/EBP (1:2000),
C/EBP (1:2000, Abcam), C/EBP (1:2000, Abcam), PPAR
(1:2000, Abcam), adiponectin (1:3000, Abcam), LPL (1:2000,
Abcam), aP2 (1:2000, Abcam), and apelin (1:3000, Abcam).
Rabbit secondary antibody was used at a concentration of
1:5000 except for aP2,which used a chicken secondary antibody
at a concentration of 1:5000.
RESULTS
We recently reported that MCP-1 binding to CCR2 leads to
the induction of a novel zinc finger protein, calledMCPIP, that
can induce cell death (8) or differentiation leading to angiogen-
esis (10). MCP-1 production by preadipocytes has been
FIGURE 2. DMI-induced adipocyte differentiation of 3T3-L1 fibroblast cells elicited an early increase in MCPIP expression. 3T3-L1 fibroblasts were
treated with or without DMI. RNA was collected at 1–4 days after treatment. Real time RT-PCR was used to measure MCPIP (A), and the known adipogenesis
markers C/EBP (B), C/EBP (C), C/EBP (D), and PPAR (E). Resultswere normalized to-actin;Ct values of treated/untreated are displayed (* p 0.02).
F, immunoblot analysis was performed with cell lysate collected at the same time points with antibodies against MCPIP, C/EBP, C/EBP, C/EBP, and PPAR,
G–K, results in Fwere quantified against GAPDH (* p 0.02; # p 0.03; error bars p 0.05). All experiments were repeated three times.
Adipogenesis Induction byMCPIP without PPAR
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detected (11), and in a tissue engineeringmodel of adipogenesis
MCP-1 treatment was reported to increase adipose tissue mass
in vivo (9). In view of these observations that suggest the possi-
bility of a role for MCP-1 in adipogenesis, we tested whether
differentiation of 3T3-L1 cells into adipocytes involvesMCP-1.
First, we tested whether 3T3-L1 cells were induced to produce
MCP-1 by DMI medium. Real time RT-PCR showed that
MCP-1 transcript level reached maxima 4 h after treatment
with DMI medium compared with non-DMI-containing
medium (Fig. 1A). We then tested whether MCP-1 treatment
could induce differentiation of 3T3L-1 cells into adipocytes in a
non-DMI-containing medium. MCP-1 treatment induced
expression of the C/EBP family of transcription factors and
PPAR that is known to be induced during differentiation of
3T3-L1 cells into adipocytes (Fig. 1B). C/EBP and C/EBP
were induced early followed by induction of C/EBP and
PPAR. Induction of these adipogenesis-associated transcrip-
tion factors was clearly seen at the transcript level determined
by real time PCR analysis and at the protein level as determined
by immunoblot analysis (Fig. 1, B and C). MCP-1 treatment
induced adipocytemarkers. Induction of adiponectin, LPL, and
AP2 was clearly seen at the transcript level determined by real
time PCR and protein level as determined by immunoblot anal-
ysis (Fig. 1, D and E). Microscopic examination revealed lipid
FIGURE 3. Knockdown of MCPIP inhibited DMI-induced adipogenesis. 3T3-L1 fibroblasts were treated with siRNA specific for MCPIP for 24 h before
treatment with DMI. A, RNA was isolated from all samples 7 days after DMI treatment and was evaluated for transcript levels for the adipocyte markers,
adiponectin, and LPLbyusing RT-PCR;-actin served as a control. B, immunoblot analysiswas performedwith cell lysate collected fromall samples 7 days after
DMI treatment. The samples were evaluated for the adipocyte markers adiponectin and LPL. C, results in Bwere quantified against GAPDH (* p 0.02; #
p 0.03).NS siRNA, nonspecific (scrambled) siRNA.D–G, RNAwas isolated from samples 1–4 days after DMI treatment. Real time RT-PCRwas used tomeasure
transcript levels of C/EBP, C/EBP, C/EBP, and PPAR. -Actin served as a control;Ct values of treated/untreated are displayed. * p 0.02; # p
0.03. H, cells were stained with Oil Red-O 8 days after treatment with DMI. All experiments were repeated three times.
Adipogenesis Induction byMCPIP without PPAR
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FIGURE 4. Forced expression of MCPIP-induced adipogenesis without DMI in 3T3-L1 cells. 3T3-L1 fibroblasts were transfected with MCPIP-GFP or GFP
alone. RNA and cell lysatewere collected 0.5, 1, 3, and 5 days after transfection. Transcript levels ofMCPIP (A), and the adipogenesismarkers C/EBP (B), C/EBP
(C), C/EBP (D), and PPAR (E) weremeasured using real time RT-PCR (normalized to-actin;Ct values ofMCPIP-GFP/GFP are displayed; * p 0.02; #
p0.03; error barsp0.05). F,protein levels ofMCPIP, C/EBP, C/EBP, C/EBP, andPPARweremeasuredusing immunoblot analysis.G–K, results in Fwere
quantified against GAPDH (* p 0.02). RNA and cell lysatewere collected 7 days after transfection. L, transcript levels of the adipocytemarkers, adiponectin
and LPL, weremeasured using RT-PCR; -actin served as a control;Ct values of MCPIP-GFP/GFP are displayed.M, protein levels of the adipocytemarkers,
adiponectin and LPL, weremeasured using immunoblot analysis.N andO, results inMwere quantified against GAPDH (* p 0.02). P, cells were stainedwith
Oil Red-O 8 days after transfection. All experiments were repeated three times.
Adipogenesis Induction byMCPIP without PPAR
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body accumulation. Oil Red-O staining revealed robust accu-
mulation of lipid bodies (Fig. 1F). We tested whether MCP-1-
induced adipogenesis is mediated via MCPIP. Upon MCP-1
treatment, MCPIP was induced to a maximal level during the
1st day (Fig. 1G). This induction was clear from real time PCR
measurement of the transcript level and from the immunoblot
analysis ofMCPIPprotein level. After the 2nddayMCPIP levels
decreased. This result is consistent with the involvement of
MCPIP in adipogenesis.
IfMCPIP is a key player in adipogenesis, it should be induced
early during the adipocyte differentiation and induced in
3T3-L1 cells by the commonly used adipogenesis-inducing
DMI medium. The levels of MCPIP, C/EBP, and C/EBP
reached maximal levels during the first 2 days. Induction of
PPAR and C/EBP followed as expected (Fig. 2). ThatMCPIP
plays a critical role in adipogenesis is indicated by the finding
that knockdown of MCPIP expression with siRNA specific for
MCPIP inhibited adipogenesis induced by DMI medium,
whereas nonspecific (scrambled) siRNA had very little effect
(Fig. 3, A–H). This inhibition was demonstrated by the inhibi-
tion of appearance of adipocyte markers adiponectin and LPL
at the transcript level as indicated by real timeRT-PCR (Fig. 3A)
and at the protein level as measured by immunoblot analysis
(Fig. 3, B and C). In addition, real time RT-PCR measurements
of transcript levels showed that knockdown of MCPIP expres-
sion resulted in inhibition of induction of the known adipo-
genesis-associated transcription factors C/EBP, C/EBP,
C/EBP, and PPAR (Fig. 3,D–G). Staining of the cells withOil
Red-O after 8 days of differentiation in DMI medium showed
that knockdown of MCPIP by treatment with siRNA, specific
for MCPIP, drastically inhibited lipid droplet accumulation,
whereas nonspecific siRNA had little effect (Fig. 3H). Measure-
ment of Oil Red-O extracted from stained cells also shows that
knockdown of MCPIP inhibited lipid accumulation (data not
shown). These results suggest thatMCPIP plays a critical role in
adipogenesis induced by DMI.
If MCPIP is one of the critical regulators involved in adipo-
genesis, forced expression of MCPIP in 3T3-L1 cells might be
expected to cause induction of adipogenesis in the absence of
adipogenesis-inducing DMI mixture. Transfection of 3T3-L1
cells with an expression construct for MCPIP-GFP caused the
induction of adipogenesis in the absence of DMI medium,
whereas GFP controls did not show differentiation (Fig. 4).
Forced expression ofMCPIP induced the expression of the well
established cascade of gene expression known to occur in DMI
medium. MCPIP expression induced C/EBP, C/EPB,
C/EBP, and PPAR, the transcription factorswell known to be
involved in adipogenesis. The induction of these transcription
factors was seen both at the transcript levels measured by real
time RT-PCR (Fig. 4, B–E) and at a protein level measured by
immunoblot analyses (Fig. 4, F–K). C/EBP and C/EBP levels
reached maximal levels before C/EBP and PPAR levels
reached maximal levels as seen in DMI medium. MCPIP-in-
duced adipogenesis was demonstrated by the induction of adi-
pocyte markers, adiponectin and LPL, both at the transcript
level as indicated by real time RT-PCR and at protein level as
measured by immunoblot analysis (Fig. 4, L–O). Staining of the
cells transfected with MCPIP-GFP expression plasmid, after 8
days in non-DMI medium showed strong staining of lipid bod-
ies, whereas GFP controls showed no staining (Fig. 4P). Thus it
is clear that MCPIP expression can induce adipogenesis in
3T3-L1 cells in the absence of the usual adipogenesis-inducing
factors in themedium.MCP-1 treatment and forced expression
of MCPIP in non-DMI medium caused accumulation of lipid
droplets comparable with that observed in the DMI medium,
although the DMI medium induced the most robust degree of
lipid droplet accumulation. This conclusion is based on mor-
phometric quantitative analysis of the stained plates (Fig. 5).
In view of the currently held view that adipogenesis cannot
be induced in the absence of PPAR, we tested whether forced
expression of MCPIP can induce adipogenesis in PPAR/
MEFs. We transfected PPAR/ cells with MCPIP-GFP
expression plasmids or GFP control and incubated them in
DMImedium. Forced expression of MCPIP in PPAR/ cells
caused induction of the C/EBP family of transcription factors,
C/EBP, C/EBP, and C/EBP, as seen both at the transcript
level asmeasured by real time PCR (Fig. 6A) and at protein level
asmeasured by immunoblot analysis (Fig. 6,B–E). TheMCPIP-
GFP-transfected cells exhibited adipogenesis as indicated by
induction of adipocyte markers, Ap2, adiponectin, and LPL, as
measured by immunoblot analysis (Fig. 6, F and G), whereas
GFP controls showed very little induction. Microscopic exam-
ination of the Oil Red-O-stained cells showed robust accumu-
lation of lipid droplets in MCPIP-GFP-transfected PPAR/
cells, whereas GFP controls showed little lipid accumulation
(Fig. 6H). Because this result is contrary to the currently
accepted view that PPAR is necessary for adipogenesis, we
confirmed that the PPAR/ MEFs we used were, in fact,
PPAR/ as reported by the authors who generated this
PPAR null cell line (12) and as indicated under “Experimental
Procedures.” Immunoblot analysis confirmed the absence of
FIGURE 5. Treatment of 3T3-L1 cells with MCP-1 or transfection with
MCPIP-GFP resulted inoil dropletaccumulationcomparablewith3T3-L1
cells treated with the classical mixture DMI. 3T3-L1 fibroblasts were
treated with DMI or MCP-1 or were transfected with MCPIP-GFP. Cells were
stainedwithOil Red-O8days after treatment. Imagesofplateswere captured,
and stainingwasmeasured usingmorphometric software analysis. Quantita-
tion of lipid accumulation in the entire plate was done on the basis of total
stainedarea, numberof cells stained, and intensity of staining. All threemeth-
ods yielded similar results. The results obtained on the basis of total area
stained are displayed.
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PPAR protein (Fig. 6I). Thus, MCPIP expression can induce
adipogenesis in the absence of PPAR.
DISCUSSION
The results presented here constitute the discovery of a
previously unknown key player that can induce adipogenesis
in the absence of PPAR that is currently thought to be nec-
essary and sufficient for adipogenesis. The central role of
MCPIP in adipogenesis was demonstrated by the finding
that MCP-1 production was induced very early after 3T3-L1
cells were placed in DMI medium. Furthermore, MCP-1
treatment of 3T3-L1 cells induced adipogenesis. This direct
demonstration of MCP-1 induction of adipogenesis is con-
sistent with a recent report that MCP-1 enhanced new adi-
pose tissue formation in vivo (9). Adipogenic precursor cells
are known to have CCR2 (13). Because MCPIP is induced by
the signaling process resulting fromMCP-1 interaction with
its receptor CCR2 (8), the present results have implications
on the role of MCP-1/CCR2 in obesity and type 2 diabetes. In
diet-induced insulin resistance, mcp-1 gene expression in
adipose tissue increases in ob/ob and db/dp mice (14). Adi-
pocyte-specific overexpression of MCP-1 in mice results in
increased macrophage recruitment to adipose tissue and
causes hepatic steatosis and insulin resistance in liver and
muscle as well as fat tissue. In CCR2/mice, recruitment of
monocytes/macrophages into adipose tissue is inhibited,
and development of obesity-induced insulin resistance is
attenuated (15). Macrophage recruitment and consequent
inflammatory response in adipose tissue result in secretion
of more MCP-1, tumor necrosis factor-, and interleukin-
(16). These agents cause increase in lipolysis and decrease in
triacylglycerol synthesis leading to increased levels of fatty
acids and in the availability of triacylglycerols for uptake
directly into skeletal muscle (3). These excess circulating
lipids cause accumulation of fatty acyl-CoA in skeletal mus-
cle, liver, and  cells leading to insulin resistance and type 2
diabetes (17, 18). The inflammatory stress causes interleu-
kin-6 secretion from the adipose tissue that leads to expres-
sion of suppressor of cytokine signaling expression that is
known to induce hepatic insulin resistance (19). Thus, there
is strong evidence for a key role that MCP-1/CCR2 system
plays in obesity and type 2 diabetes. The role of MCP-1 in
this process has been questioned on the basis that macro-
phage accumulation in adipose tissue was not significantly
attenuated in MCP-1-deficient mice (20). However, MCP-5
can substitute as a CCR2 ligand in mice (21).
The exact source of MCP-1 in adipose tissue is not known,
although there are several possibilities. Obesity is well
known to cause elevation ofMCP-1 levels. The resident mac-
rophages and macrophages infiltrating the adipose tissue
could produce MCP-1. MCP-1 production could also be
caused by endotoxemia from gut flora elevated by feeding
(22). Death of adipocytes could release MCP-1, as dying cells
are known to release MCP-1 (23). Adipose tissue in obese
animals is reported to have localized hypoxia that could lead
to hypoxia-inducible factor induction and MCP-1 produc-
tion (24, 25).We have found that under hypoxia humanmac-
rophages secreteMCP-1. In adipose tissuemacrophage-con-
taining areas were found to be hypoxic, and thus these
macrophages would also produce MCP-1.
We show thatMCP-1 binding toCCR2, which is known to be
present in fibroblasts and preadipocytes (13, 26), caused
MCPIP induction before C/EBP and C/EBP were induced.
Furthermore, knockdown of MCPIP expression inhibited the
induction of these transcription factors and drastically inhib-
ited adipogenesis. Forced expression of MCPIP induced the
cascade of transcription factors well known to be induced by
DMI medium leading to robust adipogenesis. Thus MCPIP
expression induced adipogenesis via the already known
sequence of induction of transcription factors and expres-
sion of adipogenesis markers. MCPIP induction is one of the
earliest events in adipogenesis, and MCPIP-induced adipo-
genesis was associated with PPAR induction. What was
surprising was that MCPIP expression could induce adipo-
genesis in PPAR/ cells in which no other factor has pre-
viously been able to induce adipogenesis. This finding shows
that MCPIP is a key regulator of adipogenesis.
How exactly MCPIP induces the expression of the C/EBP
family of transcription factors that would lead to adipogenesis
remains to be elucidated. Considering the finding that MCPIP
is induced before the induction of the C/EBP family, it appears
possible that the role ofMCPIP is to induce the early transcrip-
tions factorsC/EBP andC/EBP, whichwould then lead to the
induction of subsequent factors required for adipogenesis.
C/EBP and PPAR can induce each other. However, C/EBP
cannot induce adipogenesis without PPAR. Our results dem-
onstrate that MCPIP can induce C/EBP and adipogenesis
without PPAR. Thus, MCPIP can be considered a critical reg-
ulator of adipogenesis.
There is overwhelming evidence that demonstrates a key role
forCCR2-mediated events in obesity anddevelopment of type 2
diabetes. Our results show that the MCP-1/CCR2 system plays
a direct role in adipogenesis. There is experimental evidence
that MCP-1 can promote angiogenesis (27, 28) and that this
MCP-1-induced angiogenesis is mediated via MCPIP (10).
Thus, MCPIP induced by MCP-1/CCR2 interaction promotes
adipogenesis and angiogenesis to supply blood to growing adi-
pose tissue. These findings help provide a molecular basis for
FIGURE 6. Forced expression of MCPIP in PPAR/ fibroblasts induced adipogenesis. PPAR/ fibroblasts were transfected with MCPIP-GFP or GFP
alone and were evaluated for adipogenesis. A, RNA was collected from PPAR/ fibroblasts 1, 3, and 5 days after transfection with MCPIP-GFP or GFP alone.
Transcript levels of C/EBP, C/EBP , and C/EBP were evaluated using real time RT-PCR; -actin served as a control; Ct values of MCPIP-GFP/GFP are
displayed (* p 0.02). B, cell lysate was collected from the same samples and were evaluated via immunoblot for C/EBP, C/EBP, and C/EBP. C–E, results
in Bwere quantified against GAPDH (* p 0.02; # p 0.03). F, immunoblot analysis was performed with cell lysate collected from all samples 1, 3, 5, and
7 days after transfection. Samples were evaluated for the adipocytemarkers AP2, adiponectin, and LPL.G, results in Awere quantified against GAPDH (* p
0.02).H, cells were treated with Oil Red-O 8 days after transfection andweremicroscopically evaluated. I, PPAR/ or PPAR/ fibroblasts were transfected
with MCPIP-GFP. Samples were evaluated for PPAR using immunoblot analysis. All experiments were repeated three times.
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the role of the MCP-1/CCR2 system in the development of
obesity and consequent development of type 2 diabetes.
Acknowledgment—We thank Dr. Bruce Spiegelman from Harvard
University for the PPAR/ cell line.
REFERENCES
1. Ogden, C. L., Carroll, M. D., Curtin, L. R., McDowell, M. A., Tabak, C. J.,
and Flegal, K. M. (2006) JAMA 295, 1549–1555
2. Rosen, E. D., and Spiegelman, B. M. (2006) Nature 444, 847–853
3. Guilherme, A., Virbasius, J. V., Vishwajeet, P., and Czech, M. P. (2008)
Nat. Rev. Mol. Cell Biol. 9, 367–377
4. Rosen, E. D., and MacDougald, O. A. (2006) Nat. Rev. Mol. Cell Biol. 7,
885–896
5. Wu, Z., Rosen, E. D., Brun, R., Hauser, S., Adelmant, G., Troy, A. E.,
McKeon, C., Darlington, G. J., and Spiegelman, B. M. (1999) Mol. Cell 3,
151–158
6. Rosen, E. D., Hsu, C. H., Wang, X., Sakai, S., Freeman, M. W., Gonzalez,
F. J., and Spiegelman, B. M. (2002) Genes Dev. 16, 22–26
7. Lefterova, M. I., and Lazar, M. A. (2009) Trends Endocrinol. Metab. 20,
107–114
8. Zhou, L., Azfer, A., Niu, J., Graham, S., Choudhury, M., Adamski, F. M.,
Younce, C., Binkley, P. F., and Kolattukudy, P. E. (2006) Circ. Res. 98,
1177–1185
9. Hemmrich, K., Thomas, G. P., Abberton, K. M., Thompson, E. W.,
Rophael, J. A., Penington, A. J., and Morrison, W. A. (2007) Obesity 15,
2951–2957
10. Niu, J., Azfer, A., Zhelyabovska, O., Fatma, S., and Kolattukudy, P. E.
(2008) J. Biol. Chem. 283, 14542–14551
11. Wang, B., Jenkins, J. R., and Trayhurn, P. (2005)Am. J. Physiol. Endocrinol.
Metab. 288, E731–E740
12. Rosen, E. D., Sarraf, P., Troy, A. E., Bradwin, G.,Moore, K.,Milstone, D. S.,
Spiegelman, B. M., and Mortensen, R. M. (1999)Mol. Cell 4, 611–617
13. Gerhardt, C. C., Romero, I. A., Cancello, R., Camoin, L., and Strosberg,
A. D. (2001)Mol. Cell. Endocrinol. 175, 81–92
14. Kanda, H., Tateya, S., Tamori, Y., Kotani, K., Hiasa, K., Kitazawa, R.,
Kitazawa, S., Miyachi, H., Maeda, S., Egashira, K., and Kasuga, M. (2006)
J. Clin. Invest. 116, 1494–1505
15. Weisberg, S. P., Hunter, D., Huber, R., Lemieux, J., Slaymaker, S., Vaddi,
K., Charo, I., Leibel, R. L., and Ferrante, A.W., Jr. (2006) J. Clin. Invest. 116,
115–124
16. Lagathu, C., Yvan-Charvet, L., Bastard, J. P., Maachi, M., Quignard-Bou-
lange´, A., Capeau, J., and Caron, M. (2006) Diabetologia 49, 2162–2173
17. Unger, R. H. (1995) Diabetes 44, 863–870
18. Unger, R. H. (2002) Annu. Rev. Med. 53, 319–336
19. Sabio, G., Das,M.,Mora, A., Zhang, Z., Jun, J. Y., Ko, H. J., Barrett, T., Kim,
J. K., and Davis, R. J. (2008) Science 322, 1539–1543
20. Inouye, K. E., Shi, H., Howard, J. K., Daly, C. H., Lord, G. M., Rollins, B. J.,
and Flier, J. S. (2007) Diabetes 56, 2242–2250
21. Sarafi,M.N., Garcia-Zepeda, E. A.,MacLean, J. A., Charo, I. F., and Luster,
A. D. (1997) J. Exp. Med. 185, 99–109
22. Cani, P. D., Amar, J., Iglesias, M. A., Poggi, M., Knauf, C., Bastelica, D.,
Neyrinck, A. M., Fava, F., Tuohy, K. M., Chabo, C., Waget, A., Delme´e, E.,
Cousin, B., Sulpice, T., Chamontin, B., Ferrie`res, J., Tanti, J. F., Gibson,
G. R., Casteilla, L., Delzenne, N. M., Alessi, M. C., and Burcelin, R. (2007)
Diabetes 56, 1761–1772
23. Kobara, M., Sunagawa, N., Abe, M., Tanaka, N., Toba, H., Hayashi, H.,
Keira, N., Tatsumi, T., Matsubara, H., and Nakata, T. (2008) J. Appl.
Physiol. 104, 601–609
24. Hosogai, N., Fukuhara, A., Oshima, K., Miyata, Y., Tanaka, S., Segawa, K.,
Furukawa, S., Tochino, Y., Komuro, R., Matsuda, M., and Shimomura, I.
(2007) Diabetes 56, 901–911
25. Ye, J., Gao, Z., Yin, J., and He, Q. (2007) Am. J. Physiol. Endocrinol. Metab.
293, E1118–E1128
26. Hogaboam, C. M., Bone-Larson, C. L., Lipinski, S., Lukacs, N. W., Chen-
sue, S. W., Strieter, R. M., and Kunkel, S. L. (1999) J. Immunol. 163,
2193–2201
27. Salcedo, R., Ponce, M. L., Young, H. A., Wasserman, K., Ward, J. M.,
Kleinman, H. K., Oppenheim, J. J., and Murphy, W. J. (2000) Blood 96,
34–40
28. Hong, K. H., Ryu, J., and Han, K. H. (2005) Blood 105, 1405–1407
Adipogenesis Induction byMCPIP without PPAR
27628 JOURNAL OF BIOLOGICAL CHEMISTRY VOLUME 284•NUMBER 40•OCTOBER 2, 2009
 at U
CF H
ealth Sciences Library on Septem
ber 24, 2019
http://w
w
w
.jbc.org/
D
ow
nloaded from
 
Craig W. Younce, Asim Azfer and Pappachan E. Kolattukudy
γPeroxisome Proliferator-activated Receptor 
Zinc Finger Protein, Induces Adipogenesis in 3T3-L1 Pre-adipocytes without 
MCP-1 (Monocyte Chemotactic Protein-1)-induced Protein, a Recently Identified
doi: 10.1074/jbc.M109.025320 originally published online August 7, 2009
2009, 284:27620-27628.J. Biol. Chem. 
  
 10.1074/jbc.M109.025320Access the most updated version of this article at doi: 
 Alerts: 
  
 When a correction for this article is posted•  
 When this article is cited•  
 to choose from all of JBC's e-mail alertsClick here
  
 http://www.jbc.org/content/284/40/27620.full.html#ref-list-1
This article cites 28 references, 12 of which can be accessed free at
 at U
CF H
ealth Sciences Library on Septem
ber 24, 2019
http://w
w
w
.jbc.org/
D
ow
nloaded from
 
